In the last ten years, the rapid expansion of oncology knowledge, with numerous new therapeutic targets, drug approvals, early interventions, along with an exponentially increased number of clinical trials, have dramatically complexified treatment algorithms and been responsible for a significant rise in cancer-related survival rates [1,2]. International guidelines often struggle to keep pace with the rapid advancements of discoveries and…
Will AI Write the Next "Chapter" in Literature Reviews?
Annals of Oncology | | Felix Blanc-Durand, Miriam Koopman, Sandip Pravin Patel, Mihaela Aldea, Jakob Nikolas Kather
Topics: blood-cancer, breakthrough-drugs, clinical-trials, research